Stephen T. Man
Cardiff, WLS CF144XN, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Use of an anti-CD200-blocking antibody improves immune responses to AML in vitro and in vivo.
Journal: British journal of haematology
Published: August 02, 2020
Synthetic Peptides with Inadvertent Chemical Modifications Can Activate Potentially Autoreactive T Cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: June 24, 2020
Increased frequency of CD4+ PD-1+ HLA-DR+ T cells is associated with disease progression in CLL.
Journal: British journal of haematology
Published: August 08, 2019
Chronic lymphocytic leukaemia: the role of T cells in a B cell disease.
Journal: British journal of haematology
Published: April 05, 2019
Cytomegalovirus infection does not impact on survival or time to first treatment in patients with chronic lymphocytic leukemia.
Journal: American journal of hematology
Published: March 05, 2016
Systemic listeriosis following vaccination with the attenuated Listeria monocytogenes therapeutic vaccine, ADXS11-001.
Journal: Human vaccines & immunotherapeutics
Published: December 01, 2015
CD8+ T-cell specificity is compromised at a defined MHCI/CD8 affinity threshold.
Journal: Immunology and cell biology
Published: November 09, 2015
The immunosuppressive ligands PD-L1 and CD200 are linked in AML T-cell immunosuppression: identification of a new immunotherapeutic synapse.
Journal: Leukemia
Published: March 10, 2015
Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial.
Journal: The Lancet. Oncology
Published: October 12, 2014
Last Updated: 09/26/2026